• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Sunday, June 21, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Challenge of dengue fever

Published on: December 11, 2015 9:46 PM

Sir: The planet of earth is rich in eternal beauty but the prosperity and tranquility provided by nature to this part of the universe is in shambles today. High population growth rate, urbanisation, global warming and new environmental constraints are evolving the issue of disease outbreaks and dengue fever is one of them. South Asia, South East Asia, Africa and South America are those hapless continents in which the maledictions of dengue virus are yet to be eradicated.

 

The dengue virus has exposed itself in five serotypes throughout the globe. Humans are the primary host of the virus. A female mosquito that takes a blood meal from a person infected with dengue fever becomes itself infected with the virus which also includes her salivary glands. The infected mosquito lays its eggs in artificial water containers and feed on human beings. When a mosquito carrying dengue virus bites a person, the virus enters the skin together with the mosquito’s saliva. Fever, myalgia, headache, nausea, vomiting, diarrhea and a rash are the initial symptoms of dengue fever which are followed by petechia, positive tourniquet test and mild bleeding from the mucous membranes of the mouth and nose. In some cases, the infection may progress to the dengue shock syndrome and dengue hemorrhagic fever.

 

Currently there is no licenced vaccine and antiviral drug to beat the perils in the affected regions. Various research institutes and pharmaceutical companies should be sponsored and patronised for swift invention of an effective vaccine and antiviral drug.

 

The elimination of the dengue virus demands both long term and short term plans. The affected countries need to undertake an exercise of screening their citizens for timely detection of the virus and isolation of the affected individuals.

 

DR FAISAL ALI

 

Abbottabad

Filed Under: Letters

Submit a Comment




Primary Sidebar




Latest News

Trump hails PM, CDF Munir for helping US clinch Iran deal

Iran shuts Hormuz again; Swiss talks to start today

Seven martyred, three injured in back-to-back explosions in Bannu

Qureshi acquitted, Dr Yasmin, others sentenced to 10 years in May 9 case

Government lifts austerity measures after fuel prices drop

Pakistan

Trump hails PM, CDF Munir for helping US clinch Iran deal

Iran shuts Hormuz again; Swiss talks to start today

Seven martyred, three injured in back-to-back explosions in Bannu

Qureshi acquitted, Dr Yasmin, others sentenced to 10 years in May 9 case

Government lifts austerity measures after fuel prices drop

More Posts from this Category

Business

Iraq forecasts oil production recovery soon

Tax share in petrol, diesel revealed

Solar panel prices crash after fuel cut

Jet fuel price slashed in Pakistan

Aurangzeb defends budget, promises tax relief

More Posts from this Category

World

Spanish judge orders PM’s wife to face corruption trial, surrender passport

Meloni hits back as Trump escalates G7 photo spat

Israeli fire kills 10 people in Gaza

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.